Ellen de Kort

123 Propofol for intubation in neonates 7 REFERENCES 1. Maheshwari R, Tracy M, Badawi N, Hinder M. Neonatal endotracheal intubation: how to make it more baby friendly. J Paediatr Child Health 2016;52:480-486. 2. Marshall TA, Deeder, R, Pai, Berkowitz GP, Austin TL. Physiological changes associated with endotracheal intubation in preterm infants. Crit Care Med 1984;12:501-503. 3. KellyM, Finer N. Nasotracheal intubation in the neonate: physiological responses and the effect of atropine and pancuronium. J Pediatr 1984;105:303-309. 4. Millar C, Bissonnette B. Awake intubation increases intracranial pressure without affecting cerebral blood flow velocity in infants. Can J Anaesth 1994;41:281-287. 5. Bhutada A, Sahni R, Rastogi S, Wung JT. Randomised controlled trial of thiopental for intubation in neonates. Arch Dis Child Fetal Neonatal Ed 2000;82:F34-F37. 6. Oei J, Hari R, Butha T, Lui K. Facilitation of neonatal nasotracheal intubation with premedication: a randomized controlled trial. J Paediatr Child Health 2002;38:146-150. 7. Barrington KJ, Finer NN, Etches PC. Succinylcholine and atropine for premedication of the newborn infant before nasotracheal intubation: a randomized, controlled trial. Crit Care Med 1989;17:1293-1296. 8. Whyte S, Birrell G, Wyllie J. Premedication before intubation in UK neonatal units. Arch Dis Child Fetal Neonatal Ed 2000;82:F38-F41. 9. Chaudhary R, Chonat S, Gowda H, Clarke P, Curley A. Use of premedication for intubation in tertiary neonatal units in the United Kingdom. Paediatr Anaesth 2009;19:653-658. 10. Kelleher J, Mallya P, Wyllie J. Premedication before intubation in UK neonatal units: a decade of change? Arch Dis Child Fetal Neonatal Ed 2009;94:F332-F335. 11. Wheeler B, Broadbent R, Reith D. Premedication for neonatal intubation in Australia and New Zealand: a survey of current practice. J Paediatr Child Health 2012;48:997-1000. 12. Kumar P, Denson SE, Mancuso TJ; Committee on fetus and newborn section on anesthesiology and pain medicine. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics 2010;125:608-615. 13. Carbajal R, Eriksson M, Courtois E, Boyle E, Avila-Alvarez A, Doyland Andersen R, et al.; on behalf of the EUROPAIN SurveyWorking Group. Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study. Lancet Resp Med 2015;3:796-812. 14. Flint RB, Van Beek F, Andriessen P, Zimmerman LJ, Liem KD, Reiss IKM et al.; DINO Research Group. Large differences in neonatal drug use between NICUs are common practice: time for consensus? Br J Clin Pharmacol 2018;84:1313-1323. 15. Nauta M, Onland W, De Jaegere A. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm infants. Paediatr Anaesth 2011;21:711-712. 16. Welzing L, Kribs A, Eifinger F, Huenseler C, Oberthuer A, Roth B. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates. Paediatr Anaesth. 2010;20:605-611. 17. Simons SHP, van der Lee R, Reiss IKM, van Weissenbruch MM. Clinical evaluation of propofol as sedative for endotracheal intubation in neonates. Acta Paediatr 2013;102:e487-e492. 18. Ghanta S, Abdel-Latif ME, Lui K, Ravindranathan H, Awad J, Oei J. Propofol compared with the morphine, atropine and suxamethonium regimen as induction agent for neonatal endotracheal intubation: a randomized, controlled trial. Pediatrics. 2007;119:e1248-e1255.

RkJQdWJsaXNoZXIy ODAyMDc0